Milad Ibrahim

6PUBLICATIONS
34CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 03, 2026
Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells.

|Feb 06, 2026
NF1 Loss Remodels Tumor Niches for Immune Evasion.

Milad Ibrahim, Irineu Illa-Bochaca, Tara Muijlwijk

|Jun 24, 2025
Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.

Faisal Fa'ak, Nicolas Coudray, George Jour

|Jun 10, 2025
NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma.

Milad Ibrahim, Irineu Illa-Bochaca, George Jour

|Jun 05, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Kelsey R Monson, Robert Ferguson, Joanna E Handzlik

|Jan 11, 2024
Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment Outcomes.

Milad Ibrahim, Irineu Illa-Bochaca, Faisal Fa'ak

Pageof 1

Frequent Collaborators

2 joint publications

Faisal Fa'ak

2 joint publications

Kelsey R Monson

2 joint publications

Iman Osman

2 joint publications

George Jour